Information for requestors interested in submitting animal models for qualification to FDA’s Drug Development Tool (DDT) Programs.
Similar Posts
Prescription-to-Nonprescription (Rx-to-OTC) Switches
A sponsor of a nonprescription drug product may seek to market a prescription drug product as nonprescription.Certification Process for Designated Medical Gases
This guidance explains how FDA administers the certification process and describes the annual reporting requirements for designated medical gases (DMGs).FDA Drug Competition Action Plan
FDA’s Drug Competition Action Plan (DCAP) encourages robust and timely market competition for generic drugs and helps bring greater efficiency and transparency to the generic drug review process, without sacrificing the scientific rigor underlying our generic drug program.Biosimilar Product Information
This page includes a chart of the approved biosimilar and interchangeable products. The approval of biosimilar products can improve access to care for patients by increasing the number of medication options and potentially lower costs.VITAFER-L Gold 500ml may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 500ml, a product promoted for energy and sexual enhancement on various websites, including www.amazon.com and www.walmart.com.Endico Potatoes Inc. Recalls 2.5lb Bags of Frozen “Peas And Carrots” and “Mixed Vegetables” Because of Possible Health Risk
ENDICO POTATOES of MOUNT VERNON NY is recalling Endico brand PEAS AND CARROTS AND MIXED VEGETABLES, because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and other